Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × EC regimen × Breast × Clear all

Phase

Status

Completed 6 Unknown 3 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Paclitaxel 84 Trastuzumab 63 Letrozole 62 Fulvestrant 62 pembrolizumab 57 Carboplatin 52 Cyclophosphamide 49 pertuzumab 44 palbociclib 44 Anastrozole 41 Capecitabine 34 Tamoxifen 30 Radiotherapy 29 exemestane 28 Magnetic Resonance Spectroscopy 27 Doxorubicin 27 olaparib 25 Docetaxel 25 abemaciclib 24 ribociclib 22 Specimen Handling 21 Gemcitabine 20 Epirubicin 20 130-nm albumin-bound paclitaxel 20 Taxes 19 durvalumab 18 Alpelisib 18 eribulin 17 Surveys and Questionnaires 17 trastuzumab deruxtecan 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03609047 2024-01-24

Appalaches

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡